Pharmaceuticals, Biotechnology and Life Sciences
Exosome-Based ExoPTEN Targets Three High-Value Nerve Injury IndicationsTORONTO and HAIFA, Israel, April 24, 2025 (GLOBE NEWSWIRE) — NurExone Biologic Inc.…
Cash and cash equivalents totaled €81.8 million as of December 31, 2024. In addition, completion in early 2025 of: (i)…
FREMONT, Calif., April 24, 2025 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it…
GARDEN CITY, N.Y., April 24, 2025 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a…
REDWOOD CITY, Calif., April 24, 2025 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a…
New study establishes CHIPS as a foundation for engineered, vascularized, insulin-producing tissue systemsWALTHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) —…
Presentations underscore long-term clinical outcomes, safety and durability in BPH treatment Attendees invited to experience hands-on HYDROS Robotic System demonstrations SAN…
► Biomarker signatures were developed to predict histological treatment response to lanifibranor treatment in patients with MASH and fibrosis ► The…
LONDON, April 24, 2025 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a…
COPENHAGEN, Denmark, April 24, 2025 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report first quarter…